全球傳染病診斷市場預測(~2028):按技術(常規、分子型)、最終用戶(醫院/診所、診斷參考實驗室、學術研究所)、按地區分析
市場調查報告書
商品編碼
1064157

全球傳染病診斷市場預測(~2028):按技術(常規、分子型)、最終用戶(醫院/診所、診斷參考實驗室、學術研究所)、按地區分析

Infectious Disease Diagnostics Market Forecasts to 2028 - Global Analysis By Technique (Traditional, Molecular), End User (Hospitals & Clinics, Diagnostic Reference Laboratories, Academic Research Institutes) and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球傳染病診斷市場將從 2021 年的 281 億美元增長到 2028 年的 520.3 億美元,預計在預測期內的複合年增長率為 9.2%。

傳染病在全球範圍內爆發,對診斷測試的需求不斷增加。

本報告調查和分析全球傳染病診斷市場、市場概況、市場趨勢、產品、測試類型、疾病類型、技術、最終用戶、區域市場分析和公司。提供概況等。

目錄

第 1 章執行摘要

第2章前言

第3章市場趨勢分析

  • 促進因素
  • 抑制器
  • 市場機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

第 5 章全球傳染病診斷市場:按產品分類

  • 簡介
  • 試劑、試劑盒、耗材
  • 設備、系統
  • 軟件、服務

第 6 章全球傳染病診斷市場:按測試類型

  • 簡介
  • 臨床檢查
    • 驗血
    • 大便測試
    • 尿液分析
    • 脊髓穿刺
    • 咽拭子
  • 圖像檢測
    • 計算機斷層掃描 (CT)
    • 磁共振成像 (MRI)
    • X 射線
    • 活檢
  • 護理點 (POC) 測試

第 7 章全球傳染病診斷市場:按疾病類型

  • 簡介
  • 細菌性傳染病(耐甲氧西林金黃色葡萄球菌(MRSA))
  • 病毒感染
    • 新冠肺炎 (COVID-19)
    • 人乳頭瘤病毒(HPV)
  • 丙型肝炎
  • 乙型肝炎
  • 心血管感染
  • 真菌感染
  • 醫院感染(HAI)
  • 呼吸道感染
    • 肺結核
    • 支氣管炎
    • 流感
  • 血液感染
    • 傳染性單核細胞增多症
    • 瘧疾
    • 登革熱
  • 腹瀉病
    • 傷寒
    • 霍亂
    • 志賀氏痢疾
  • 中樞神經系統(CNS)感染
    • 腦膿腫
    • 腦膜炎
  • 性病
    • 梅毒
    • 沙眼衣原體生殖器感染、淋病(CT/NG)
    • 獲得性免疫缺陷綜合症(艾滋病)

第 8 章全球傳染病診斷市場:按技術分類

  • 簡介
  • 常規類型
    • 革蘭氏染色培養病原菌
    • □免疫法、凝集法
    • 生化表徵
    • 免疫診斷
    • 顯微鏡
  • 分子類型
    • 臨床微生物學
    • 等溫核酸擴增法(INAAT)
    • 聚合□鍊式反應 (PCR)
    • 微陣列
    • 雜交
    • 二代測序(NGS)、脫氧核糖核酸(DNA)測序

第 9 章全球傳染病診斷市場:按最終用戶分類

  • 簡介
  • 醫院/診所
  • 診斷參考實驗室
  • 學術研究所
  • 家庭醫療
  • 診所
  • 合同研究機構
  • 外科中心

第 10 章全球傳染病診斷市場:按地區劃分

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東/非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他

第 11 章主要發展

  • 合同、聯盟、合作、合資企業
  • 收購、合併
  • 推出新產品
  • 擴展
  • 其他重要策略

第 12 章公司簡介

  • Becton, Dickinson and Company(BD)
  • Abbott Diagnostic
  • Beckman Coulter
  • Siemens Healthcare Diagnostics
  • Roche Diagnostic
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Meridian Bioscience
  • Corgenix
  • Trinity Biotech
  • Eiken Chemical
  • J.Mitra
  • Diasorin
  • EMD Millipore
  • QuantuMDx
Product Code: SMRC21791

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $30.69 billion in 2022 and is expected to reach $52.03 billion by 2028 growing at a CAGR of 9.2% during the forecast period. Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. The infectious disease epidemics are exploding worldwide, raising an extensive demand for diagnostic tests.

In 2020, molecular technologies accounted for approximately 49 percent of the worldwide organ transplant diagnostics market. This was followed by serology which had a 30 percent market share. By 2031, it was forecast that the market share of molecular technologies would increase to just under 54 percent. In 2020, PCR accounted for approximately 42.7 percent of the worldwide molecular diagnostics market, while next-generation sequencing amounted to 10.4 percent of the market. By 2031, PCR was forecast to have a 43.3 percent share of the molecular diagnostics market.

Market Dynamics:

Driver:

Rising prevalence of infectious diseases

The prevalence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period. The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics. Hence, it is expected to have a positive impact on this market.

Restraint:

Inadequate reimbursement

Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

Opportunity:

Opportunities from developing economies

Developing economies such as India and South Korea are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements.

Threat:

Poor distribution channel

Diagnostic kits are expensive and manufacturers still have poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

COVID-19 Impact

Diagnostics for SARS-CoV-2 screening are being developed continuously to cater to the needs of markets with unique regulatory constraints. For example, in November 2021, Detect, a health technology firm, launched a new PCR-quality at-home COVID-19 quick molecular test to address testing needs at home, school, and work, in the United States. Likewise, CoviSwift, by Mylab Discovery Solutions, a point-of-care (POC) RT-PCR testing solution that may be utilized in small labs, in-hospital labs, airports, and communities, was approved and launched in February 2022. Similarly, Abbott introduced the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, in March 2020, and BioMedomics released a PoC COVID-19 test that can identify antibodies in blood within 15 minutes in March 2020.

The reagents, kits, and consumables segment is expected to be the largest during the forecast period

The reagents, kits, and consumables segment is expected to be the largest during the forecast period owing to the factors such as increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost. Further, the outbreak of coronavirus (COVID-19) disease is further expected to accelerate the growth of this segment owing to the national emergency declared and requirement of various kits and assays for early disease detection.

The traditional segment is expected to have the highest CAGR during the forecast period

The dominance of traditional segment is mainly attributed to factors such as the increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments.

Region with largest share:

North America is projected to hold the largest market share owing to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments. Other factors contributing to the market growth are the increasing prevalence of infectious diseases and high expenditure on healthcare, and an increase in awareness among the population regarding the availability of treatment devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Key players in the market

Some of the key players profiled in the Infectious Disease Diagnostics Market include Becton, Dickinson and Company (BD), Abbott Diagnostic, Beckman Coulter, Siemens Healthcare Diagnostics, Roche Diagnostic, Thermo Fisher Scientific, Bio-Rad Laboratories, Meridian Bioscience, Corgenix, Trinity Biotech, Eiken Chemical, J.Mitra, Diasorin, EMD Millipore, and QuantuMDx.

Key developments:

In July 2021: QuantuMDx launched the rapid polymerase chain reaction point-of-care diagnostic system called Q-POC for COVID-19.

In March 2021: Roche Diagnostics Launched cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.

In February 2021: Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

Products Covered:

  • Reagents, Kits, and Consumables
  • Instruments & Systems
  • Software & Services

Test Types Covered:

  • Laboratory Tests
  • Imaging Test
  • Point-of-Care (POC) Testing

Disease Types Covered:

  • Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))
  • Viral Infection
  • Hepatitis C
  • Hepatitis B
  • Cardiovascular Infection
  • Fungal Infection
  • Hospital Acquired Infections (HAIs)
  • Respiratory Infections
  • Blood Infections
  • Diarrheal Disease
  • Central Nervous System (CNS) Infection
  • Sexually Transmitted Diseases

Techniques Covered:

  • Traditional
  • Molecular

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Reference Laboratories
  • Academic Research Institutes
  • Home Healthcare
  • Physician Offices
  • Contract Research Organization
  • Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents, Kits, and Consumables
  • 5.3 Instruments & Systems
  • 5.4 Software & Services

6 Global Infectious Disease Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Laboratory Tests
    • 6.2.1 Blood Test
    • 6.2.2 Stool Test
    • 6.2.3 Urine Test
    • 6.2.4 Spinal Tap
    • 6.2.5 Throat Swabs
  • 6.3 Imaging Test
    • 6.3.1 Computed tomography (CT)
    • 6.3.2 Magnetic Resonance Imaging (MRI)
    • 6.3.3 X-ray
    • 6.3.4 Biopsies
  • 6.4 Point-of-Care (POC) Testing

7 Global Infectious Disease Diagnostics Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))
  • 7.3 Viral Infection
    • 7.3.1 COVID-19
    • 7.3.2 Human Papillomavirus (HPV)
  • 7.4 Hepatitis C
  • 7.5 Hepatitis B
  • 7.6 Cardiovascular Infection
  • 7.7 Fungal Infection
  • 7.8 Hospital Acquired Infections (HAIs)
  • 7.9 Respiratory Infections
    • 7.9.1 Tuberculosis
    • 7.9.2 Bronchitis
    • 7.9.3 Influenza
  • 7.10 Blood Infections
    • 7.10.1 Infectious Mononucleosis
    • 7.10.2 Malaria
    • 7.10.3 Dengue
  • 7.11 Diarrheal Disease
    • 7.11.1 Enteric/Typhoid Fever
    • 7.11.2 Cholera
    • 7.11.3 Shigellosis
  • 7.12 Central Nervous System (CNS) Infection
    • 7.12.1 Brain Abscess
    • 7.12.2 Meningitis
  • 7.13 Sexually Transmitted Diseases
    • 7.13.1 Syphilis
    • 7.13.2 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
    • 7.13.3 Acquired Immunodeficiency Syndrome (AIDS)

8 Global Infectious Disease Diagnostics Market, By Technique

  • 8.1 Introduction
  • 8.2 Traditional
    • 8.2.1 Gram-stain Pathogen Culturing
    • 8.2.2 Enzyme Immunoassay Agglutination
    • 8.2.3 Biochemical Characterization
    • 8.2.4 Immunodiagnostics
    • 8.2.5 Microscopy
  • 8.3 Molecular
    • 8.3.1 Clinical Microbiology
    • 8.3.2 Isothermal Nucleic Acid Amplification Test (INAAT)
    • 8.3.3 Polymerase Chain Reaction (PCR)
    • 8.3.4 Microarrays
    • 8.3.5 Hybridization
    • 8.3.6 Next-generation Sequencing (NGS) & Deoxyribonucleic Acid (DNA) Sequencing

9 Global Infectious Disease Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Diagnostic Reference Laboratories
  • 9.4 Academic Research Institutes
  • 9.5 Home Healthcare
  • 9.6 Physician Offices
  • 9.7 Contract Research Organization
  • 9.8 Surgical Centers

10 Global Infectious Disease Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Becton, Dickinson and Company (BD)
  • 12.2 Abbott Diagnostic
  • 12.3 Beckman Coulter
  • 12.4 Siemens Healthcare Diagnostics
  • 12.5 Roche Diagnostic
  • 12.6 Thermo Fisher Scientific
  • 12.7 Bio-Rad Laboratories
  • 12.8 Meridian Bioscience
  • 12.9 Corgenix
  • 12.10 Trinity Biotech
  • 12.11 Eiken Chemical
  • 12.12 J.Mitra
  • 12.13 Diasorin
  • 12.14 EMD Millipore
  • 12.15 QuantuMDx

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Reagents, Kits, and Consumables (2020-2028) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Instruments & Systems (2020-2028) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2020-2028) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2020-2028) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2020-2028) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Blood Test (2020-2028) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Stool Test (2020-2028) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Urine Test (2020-2028) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Spinal Tap (2020-2028) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Throat Swabs (2020-2028) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2020-2028) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By Computed tomography (CT) (2020-2028) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2020-2028) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By X-ray (2020-2028) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2020-2028) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Point-of-Care (POC) Testing (2020-2028) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2020-2028) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA)) (2020-2028) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By Viral Infection (2020-2028) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By COVID-19 (2020-2028) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2020-2028) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis C (2020-2028) ($MN)
  • Table 25 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis B (2020-2028) ($MN)
  • Table 26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular Infection (2020-2028) ($MN)
  • Table 27 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infection (2020-2028) ($MN)
  • Table 28 Global Infectious Disease Diagnostics Market Outlook, By Hospital Acquired Infections (HAIs) (2020-2028) ($MN)
  • Table 29 Global Infectious Disease Diagnostics Market Outlook, By Respiratory Infections (2020-2028) ($MN)
  • Table 30 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (2020-2028) ($MN)
  • Table 31 Global Infectious Disease Diagnostics Market Outlook, By Bronchitis (2020-2028) ($MN)
  • Table 32 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2020-2028) ($MN)
  • Table 33 Global Infectious Disease Diagnostics Market Outlook, By Blood Infections (2020-2028) ($MN)
  • Table 34 Global Infectious Disease Diagnostics Market Outlook, By Infectious Mononucleosis (2020-2028) ($MN)
  • Table 35 Global Infectious Disease Diagnostics Market Outlook, By Malaria (2020-2028) ($MN)
  • Table 36 Global Infectious Disease Diagnostics Market Outlook, By Dengue (2020-2028) ($MN)
  • Table 37 Global Infectious Disease Diagnostics Market Outlook, By Diarrheal Disease (2020-2028) ($MN)
  • Table 38 Global Infectious Disease Diagnostics Market Outlook, By Enteric/Typhoid Fever (2020-2028) ($MN)
  • Table 39 Global Infectious Disease Diagnostics Market Outlook, By Cholera (2020-2028) ($MN)
  • Table 40 Global Infectious Disease Diagnostics Market Outlook, By Shigellosis (2020-2028) ($MN)
  • Table 41 Global Infectious Disease Diagnostics Market Outlook, By Central Nervous System (CNS) Infection (2020-2028) ($MN)
  • Table 42 Global Infectious Disease Diagnostics Market Outlook, By Brain Abscess (2020-2028) ($MN)
  • Table 43 Global Infectious Disease Diagnostics Market Outlook, By Meningitis (2020-2028) ($MN)
  • Table 44 Global Infectious Disease Diagnostics Market Outlook, By Sexually Transmitted Diseases (2020-2028) ($MN)
  • Table 45 Global Infectious Disease Diagnostics Market Outlook, By Syphilis (2020-2028) ($MN)
  • Table 46 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2020-2028) ($MN)
  • Table 47 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2020-2028) ($MN)
  • Table 48 Global Infectious Disease Diagnostics Market Outlook, By Technique (2020-2028) ($MN)
  • Table 49 Global Infectious Disease Diagnostics Market Outlook, By Traditional (2020-2028) ($MN)
  • Table 50 Global Infectious Disease Diagnostics Market Outlook, By Gram-stain Pathogen Culturing (2020-2028) ($MN)
  • Table 51 Global Infectious Disease Diagnostics Market Outlook, By Enzyme Immunoassay Agglutination (2020-2028) ($MN)
  • Table 52 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2020-2028) ($MN)
  • Table 53 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2020-2028) ($MN)
  • Table 54 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2020-2028) ($MN)
  • Table 55 Global Infectious Disease Diagnostics Market Outlook, By Molecular (2020-2028) ($MN)
  • Table 56 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2020-2028) ($MN)
  • Table 57 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Test (INAAT) (2020-2028) ($MN)
  • Table 58 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2020-2028) ($MN)
  • Table 59 Global Infectious Disease Diagnostics Market Outlook, By Microarrays (2020-2028) ($MN)
  • Table 60 Global Infectious Disease Diagnostics Market Outlook, By Hybridization (2020-2028) ($MN)
  • Table 61 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (NGS) & Deoxyribonucleic Acid (DNA) Sequencing (2020-2028) ($MN)
  • Table 62 Global Infectious Disease Diagnostics Market Outlook, By End User (2020-2028) ($MN)
  • Table 63 Global Infectious Disease Diagnostics Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
  • Table 64 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Reference Laboratories (2020-2028) ($MN)
  • Table 65 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2020-2028) ($MN)
  • Table 66 Global Infectious Disease Diagnostics Market Outlook, By Home Healthcare (2020-2028) ($MN)
  • Table 67 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2020-2028) ($MN)
  • Table 68 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2020-2028) ($MN)
  • Table 69 Global Infectious Disease Diagnostics Market Outlook, By Surgical Centers (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented i